Mast Therapeutics Inc (MSTX): Mast Therapeutics rallies on heart failure data Seeking Alpha The company says MST-188 "demonstrated a statistically significant improvement in numerous parameters of heart function," in a nonclinical heart failure model. The data collected suggest the treatment may be promising way to improve left ventricular ... Mast Therapeutics Announces Positive Data In Model Of Heart Failure Mast Therapeutics optimistic after test results Breakout Stocks: Ceres Inc (NASDAQ:CERE), Mast Therapeutics Inc (NYSEMKT ... |
